Company continues to invest in intellectual property as it expands functionality of technology
Calgary, AB – November 26, 2012 - Calgary Scientific Inc., a company known for creating transformative technology that reshapes industries, announces that the organization has filed its 100th software technology patent application. The company has aggressively been protecting their leading Intellectual Property (IP) through these filings. The organization will not rest on the achievement of this landmark, but will continue to pursue patent filings on intellectual property.
Calgary Scientific engineered the leading healthcare product ResolutionMD™ and the award winning PureWeb®platform. Along with filing patent applications on their technology capabilities, the company has also received numerous accreditations for the use of their products, including CE Mark, Health Canada Approval and FDA clearance for diagnosis for ResolutionMD. ResolutionMD was one of the first products to obtain FDA clearance for diagnosis on iPhone and iPad devices. It is the only product using a virtual architecture where no patient data or files are pushed to mobile devices. This dramatically reduces bandwidth requirements and liabilities related to lost or stolen data.
The company has created an impressive portfolio of granted patents and pending applications, many filed on a global basis. The intent is to protect the organization’s future rights to their own technology; prevent competitors from developing or utilizing IP in the realms claimed by Calgary Scientific and continuously add value to the shareholders of the organization.
“Protecting intellectual property rights through patents is more important than ever before,” says Byron Osing, CEO and Chair of Calgary Scientific. “We believe that an aggressive and meaningful patent portfolio strategy is a critical component in helping ensure our customers and partners’ investment in Calgary Scientific technology is secure.”
The number of patents that the organization has been able to file with the assistance of a highly respected patent group in the U.S. is aggressive for any software company of similar size. It is also important to note that many of the patent applications are related to breaking barriers in key areas of importance to the IT industry, including mobile and cloud enablement of enterprise applications.
To see a demonstration of ResolutionMD™, PureWeb®, collaboration or any of the upcoming releases, come to booth 6244, South Hall A in Chicago, November 25 – 29, 2012.
About Calgary Scientific Inc.
Calgary Scientific is dedicated to providing advanced web-enablement, mobility enhancement and advanced visualization solutions to industries looking for secure access and use of their data or graphics intensive applications, while using their existing systems. Calgary Scientific began developing technology for the medical industry – a sector with the most rigorous demands for access, visually rich data, privacy, security and scale of any industry we aim to serve. With our FDA-cleared ResolutionMD™ technology, we have proved our ability to revolutionize healthcare, and now with the unique power of PureWeb® are doing the same for other industries. For more information on Calgary Scientific, go to www.calgaryscientific.com.
© 2012 Calgary Scientific Inc., ResolutionMD™, PureWeb® and the Calgary Scientific logo are trademarks and/or registered trademarks of Calgary Scientific. All other third-party company names and products are for identification purposes only and may be trademarks of their respective owners.
Calgary Scientific Inc.
Calgary Scientific Inc.
CEO and Chair
(+1) 403. 767. 7959